One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration

Eye

Volumn 25, Issue 8, 2011, Pages 1034-1038

  Arora, S ^a   McKibbin, M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

age related macular degeneration; pigment epithelial detachment; ranibizumab

Indexed keywords

RANIBIZUMAB;

AGED; ARTICLE; CLINICAL ARTICLE; CORNEA NEOVASCULARIZATION; DISEASE COURSE; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; INTERVENTION STUDY; LOADING DRUG DOSE; MALE; MULTICENTER STUDY (TOPIC); OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 80051748105     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.115     Document Type: Article

References (7)

1. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials- TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 1999; 117: 1329-1345
2. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al. Ranibizumab for neovascular age related macular degeneration. N Engl J Med 2006; 355: 1419-1431 (Pubitemid 44511557)
3. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RYet al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432-1444 (Pubitemid 44511558)
4. Barbazetto I, Burdan A, Bressler NM, Bressler SB, Haynes L, Kapetanios AD et al., Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation with verteporfin: fluorescein angiographic guidelines for evaluation and treatment-TAP and VIP report No. 2. Arch Ophthalmol 2003; 121: 1253-1268 (Pubitemid 37128403)
5. Ritter M, Bolz M, Sacu S, Deak G, Kiss C, Pruente C et al. Effect of intravitreal ranibizumab in avascular pigment epithelial detachment. Eye (Lond) 2009; 24(6): 962-968
6. Lommatzsch A, Heimes B, Gutfleisch M, Spital G, Zeimer M, Pauleikhoff D. Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments. Eye 2009; 23: 2163-2168
7. Chiang A, Chang LK, Yu F, Sarraf D. Predictors of anti-VEGF associated retinal pigment epithelial tear using FA and OCT analysis. Retina 2008; 28: 1265-1269